Humans deficient on functional NADPH oxidase develop chronic granulomatous disease (CGD), which is characterized by recurrent infections and limitations in elimination of intracellular microorganisms; gp91phox−/− mice kept in less sanitary conditions may also develop CGD [23, 25]. Here, FMO5 is linked to chronic granulomatous disease.